TGIF1 was shown to enhance the progression of oral squamous cell carcinoma by repressing TGF-β signaling [37], while in breast cancer and lung cancer, TGIF1 can promote tumor growth through activating Wnt/β-catenin signaling independently of TGF-β signaling [30, 31]. This evidence concerns the gene TGIF1 and lung carcinoma.